BLFS vs. AVGO

Last updated Apr 1, 2026

Compare and contrast key facts about BioLife Solutions, Inc. (BLFS) and Broadcom Inc. (AVGO).

Performance

BLFS vs. AVGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioLife Solutions, Inc. (BLFS) and Broadcom Inc. (AVGO). The values are adjusted to include any dividend payments, if applicable.

BLFS vs. AVGO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BLFS BioLife Solutions, Inc.	-21.09%	-6.86%	59.75%	-10.71%	-51.17%	-6.57%	146.54%	34.50%	100.50%	272.60%
AVGO Broadcom Inc.	-10.38%	50.63%	110.49%	104.18%	-13.27%	56.48%	44.88%	29.05%	2.18%	48.19%

Fundamentals

Market Cap BLFS : $928.15M AVGO : $1.51T
EPS BLFS : -$0.25 AVGO : $5.13
PS Ratio BLFS : 9.60 AVGO : 22.06
PB Ratio BLFS : 2.50 AVGO : 18.94
Total Revenue (TTM) BLFS : $96.21M AVGO : $68.28B
Gross Profit (TTM) BLFS : $62.12M AVGO : $46.31B
EBITDA (TTM) BLFS : -$12.13M AVGO : $36.65B

Returns By Period

In the year-to-date period, BLFS achieves a -21.09% return, which is significantly lower than AVGO's -10.38% return. Over the past 10 years, BLFS has underperformed AVGO with an annualized return of 26.42%, while AVGO has yielded a comparatively higher 38.12% annualized return.

BLFS

• 1D: 1.60%
• 1M: -21.16%
• YTD: -21.09%
• 6M: -25.21%
• 1Y: -16.46%
• 3Y*: -4.27%
• 5Y*: -12.26%
• 10Y*: 26.42%

AVGO

• 1D: 5.49%
• 1M: -2.94%
• YTD: -10.38%
• 6M: -5.81%
• 1Y: 86.36%
• 3Y*: 71.23%
• 5Y*: 48.36%
• 10Y*: 38.12%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BLFS vs. AVGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLFS

BLFS Risk / Return Rank: 20
BLFS Sharpe Ratio Rank: 26
BLFS Sortino Ratio Rank: 26
BLFS Omega Ratio Rank: 26
BLFS Calmar Ratio Rank: 16
BLFS Martin Ratio Rank: 4

AVGO

AVGO Risk / Return Rank: 86
AVGO Sharpe Ratio Rank: 89
AVGO Sortino Ratio Rank: 87
AVGO Omega Ratio Rank: 85
AVGO Calmar Ratio Rank: 86
AVGO Martin Ratio Rank: 84

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BLFS vs. AVGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BioLife Solutions, Inc. (BLFS) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BLFS	AVGO	Difference
Sharpe ratio Return per unit of total volatility	-0.33	1.80	-2.13
Sortino ratio Return per unit of downside risk	-0.16	2.52	-2.69
Omega ratio Gain probability vs. loss probability	0.98	1.33	-0.35
Calmar ratio Return relative to maximum drawdown	-0.72	2.95	-3.66
Martin ratio Return relative to average drawdown	-1.77	7.31	-9.08
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BLFS vs. AVGO - Sharpe Ratio Comparison

The current BLFS Sharpe Ratio is -0.33, which is lower than the AVGO Sharpe Ratio of 1.80. The chart below compares the historical Sharpe Ratios of BLFS and AVGO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BLFS	AVGO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.33	1.80	-2.13
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.18	1.15	-1.33
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.39	0.98	-0.59
Sharpe Ratio (All Time) Calculated using the full available price history	-0.03	1.06	-1.08

Correlation

The correlation between BLFS and AVGO is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BLFS vs. AVGO - Dividend Comparison

BLFS has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.80%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BLFS BioLife Solutions, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
AVGO Broadcom Inc.	0.80%	0.70%	0.94%	1.71%	3.02%	2.24%	3.05%	3.54%	3.11%	1.87%	1.43%	1.13%

Drawdowns

BLFS vs. AVGO - Drawdown Comparison

The maximum BLFS drawdown since its inception was -99.80%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for BLFS and AVGO.

Drawdown Indicators

	BLFS	AVGO	Difference
Max Drawdown Largest peak-to-trough decline	-99.80%	-48.30%	-51.50%
Max Drawdown (1Y) Largest decline over 1 year	-36.96%	-28.67%	-8.29%
Max Drawdown (5Y) Largest decline over 5 years	-85.14%	-41.15%	-43.99%
Max Drawdown (10Y) Largest decline over 10 years	-85.14%	-48.30%	-36.84%
Current Drawdown Current decline from peak	-86.37%	-24.75%	-61.62%
Average Drawdown Average peak-to-trough decline	-89.26%	-8.00%	-81.26%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.95%	11.56%	+3.39%

Volatility

BLFS vs. AVGO - Volatility Comparison

BioLife Solutions, Inc. (BLFS) has a higher volatility of 16.94% compared to Broadcom Inc. (AVGO) at 12.64%. This indicates that BLFS's price experiences larger fluctuations and is considered to be riskier than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BLFS	AVGO	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.94%	12.64%	+4.30%
Volatility (6M) Calculated over the trailing 6-month period	31.62%	32.48%	-0.86%
Volatility (1Y) Calculated over the trailing 1-year period	51.48%	48.26%	+3.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	66.62%	42.34%	+24.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	68.02%	38.91%	+29.11%

Financials

BLFS vs. AVGO - Profitability Comparison

The chart below illustrates the profitability comparison between BioLife Solutions, Inc. and Broadcom Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

BLFS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, BioLife Solutions, Inc. reported a gross profit of 12.68M and revenue of 18.79M. Therefore, the gross margin over that period was 67.5%.

AVGO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Broadcom Inc. reported a gross profit of 13.16B and revenue of 19.31B. Therefore, the gross margin over that period was 68.1%.

BLFS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, BioLife Solutions, Inc. reported an operating income of 5.82M and revenue of 18.79M, resulting in an operating margin of 31.0%.

AVGO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Broadcom Inc. reported an operating income of 8.56B and revenue of 19.31B, resulting in an operating margin of 44.3%.

BLFS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, BioLife Solutions, Inc. reported a net income of 3.54M and revenue of 18.79M, resulting in a net margin of 18.8%.

AVGO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Broadcom Inc. reported a net income of 7.35B and revenue of 19.31B, resulting in a net margin of 38.1%.